MDP Group will begin recruiting patients to new trial

X October 2017 – MDP Group will begin recruiting patients to a Phase XXX clinical trial in mild to moderate bronchial asthma. The study is open to children and adults with a clinical diagnosis of bronchial asthma. This study will take place in Saint Petersburg and Moscow.